Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Palom

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pharmacology & Therapeutics|April 16, 1998
The mitomycin bioreductive antitumor agents: cross-linking and alkylation of DNA as the molecular basis of their activityM Tomasz, Y Palom
Chemical Research in Toxicology|April 17, 1998
A mitomycin-N6-deoxyadenosine adduct isolated from DNAY Palom, R Lipman, S M Musser, et al.
Nucleic Acids Research|October 11, 1990
Synthesis and characterization of oligodeoxynucleotides containing the mutagenic base analogue 4-O-ethylthymineD Fernandez-Forner, Y Palom, S Ikuta, et al.
Journal of Medicinal Chemistry|August 10, 2001
Selective activation of mitomycin A by thiols to form DNA cross-links and monoadducts: biochemical basis for the modulation of mitomycin cytotoxicity by the quinone redox potentialM M Paz, A Das, Y Palom, et al.
Chemical Research in Toxicology|June 20, 2000
Structure of adduct X, the last unknown of the six major DNA adducts of mitomycin C formed in EMT6 mouse mammary tumor cellsY Palom, M F Belcourt, S M Musser, et al.
Oncology Research|May 25, 1999
Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin CY Palom, M F Belcourt, G S Kumar, et al.
Biochemistry|August 29, 2001
Solution structure of a guanine-N7-linked complex of the mitomycin C metabolite 2,7-diaminomitosene and DNA. Basis of sequence selectivityG Subramaniam, M M Paz, G Suresh Kumar, et al.
Biochemical Pharmacology|May 30, 2001
Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarolY Palom, M F Belcourt, L Q Tang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmacology & Therapeutics|April 16, 1998
The mitomycin bioreductive antitumor agents: cross-linking and alkylation of DNA as the molecular basis of their activityM Tomasz, Y Palom
Chemical Research in Toxicology|April 17, 1998
A mitomycin-N6-deoxyadenosine adduct isolated from DNAY Palom, R Lipman, S M Musser, et al.
Nucleic Acids Research|October 11, 1990
Synthesis and characterization of oligodeoxynucleotides containing the mutagenic base analogue 4-O-ethylthymineD Fernandez-Forner, Y Palom, S Ikuta, et al.
Journal of Medicinal Chemistry|August 10, 2001
Selective activation of mitomycin A by thiols to form DNA cross-links and monoadducts: biochemical basis for the modulation of mitomycin cytotoxicity by the quinone redox potentialM M Paz, A Das, Y Palom, et al.
Chemical Research in Toxicology|June 20, 2000
Structure of adduct X, the last unknown of the six major DNA adducts of mitomycin C formed in EMT6 mouse mammary tumor cellsY Palom, M F Belcourt, S M Musser, et al.
Oncology Research|May 25, 1999
Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin CY Palom, M F Belcourt, G S Kumar, et al.
Biochemistry|August 29, 2001
Solution structure of a guanine-N7-linked complex of the mitomycin C metabolite 2,7-diaminomitosene and DNA. Basis of sequence selectivityG Subramaniam, M M Paz, G Suresh Kumar, et al.
Biochemical Pharmacology|May 30, 2001
Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarolY Palom, M F Belcourt, L Q Tang, et al.
Pageof 1